Themis Medicare gets nod to transfer API business to subsidiary

08 Nov 2022 Evaluate

Themis Medicare has received approval to transfer its Active Pharmaceutical ingredients (API) business including the manufacturing facilities of the Company at Vapi, Valsad District, Gujarat and Jeedimetla, Malkajgiri District, Telangana, to Themis Lifestyle -- a subsidiary of the Company on a going concern basis. The expected date of completion of the sale of the API business of the Company is by March 31, 2023 subject to receipt of all applicable approval. Cash consideration amounting to Rs 125 crore will be payable by the transferee company to the transferor company.

Themis Medicare is a research-based pharmaceutical company specializing in manufacture of a wide range of products for application areas like Pain Management, Critical Care and Anti-Infectives.

Themis Medicare Share Price

105.60 -0.70 (-0.66%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×